Exchange: NASDAQ·Updated 07:30 PM EDT
BCYC logo

BCYC Bicycle Therapeutics Plc - ADR

$4.13
$0.07
(1.67%)
Today
Closed $4.13
$0.00
(0.00%)
After Hours
EarningsOct 29
Mkt Cap$208.05M
Vol235,608.00

About BCYC

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.
52

Neutral Sentiment

How do you feel about BCYC?

Advertisement|Remove ads.